DHL looks to strengthen presence in South American market

By Flora Southey

- Last updated on GMT


Related tags Logistics

Deutsche Post DHL Group’s contract logistics business, DHL Supply Chain, has announced its intention to acquire Brazilian transport service provider Polar Transportes. 

The São Paulo-based road carrier specialises in temperature-controlled transportation, enabling the shipment of biologic drugs and vaccines with temperature specifications.

Polar Transportes ships both Active Pharmaceutical Ingredients (APIs) and finished products to customers’ plants, from Brazilian ports and airports. Synthetic and biological drugs are among those currently transported under cold chain conditions.

DHL hopes the acquisition will strengthen its end-to-end offering for the Life Sciences and Healthcare industry in Brazil.

Polar Transportes has been working as a service provider for DHL for over 15 years. Its current network of 300 trucks allows national coverage, with greater circulation in São Paulo, Rio de Janeiro and the Goías State.

Acquiring control of our longstanding service provider Polar Transportes is…taking one more step to further foster our strong position in a key emerging market​,” said Javier Bilbao, CEO DHL Supply Chain Latin America.

While the financial terms of the acquisition have not been revealed, DHL has agreed to retain Polar Transportes’ current management team. Both companies are awaiting approval from the Brazilian competition authorities before the deal can be finalised.

The acquisition is in line with DHL’s interest in emerging markets. DHL Global Forwarding invested almost $1m (€935,462) in the market in 2016, and earlier this year announced the Group would be investing​ in four new temperature-controlled storage chambers in Puerto Rico. 

Related products

show more

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Thermo Fisher Scientific - Biosciences | 22-Mar-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Create Better Biologic Treatments with Catalent

Create Better Biologic Treatments with Catalent

Catalent | 21-Feb-2023 | Product Brochure

Deliver safe and stable products to your patients with the help of Catalent Biologics' Limoges, France site, a European Center of Excellence for early-phase...

Trends in Biopharmaceutical Raw Material Selection

Trends in Biopharmaceutical Raw Material Selection

Actylis – The Partner of Choice | 31-Jan-2023 | Business Advice

Join us as our in-house experts, along with Cecile Bellamy from Pfizer, discuss current and future trends in biopharmaceutical raw material selection.

Related suppliers

Follow us


View more